This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2004 Jun;88(6):840.

doi: 10.1136/bjo.2003.035071.

Photodynamic therapy for corneal neovascularisation and lipid degeneration

B J Brooks, B K Ambati, D M Marcus, A Ratanasit

PMID: 15148229
PMCID: PMC1772199
DOI: 10.1136/bjo.2003.035071

Case Reports

Photodynamic therapy for corneal neovascularisation and lipid degeneration

B J Brooks et al. Br J Ophthalmol. 2004 Jun.

. 2004 Jun;88(6):840.

doi: 10.1136/bjo.2003.035071.

Authors

B J Brooks, B K Ambati, D M Marcus, A Ratanasit

PMID: 15148229
PMCID: PMC1772199
DOI: 10.1136/bjo.2003.035071

No abstract available

PubMed Disclaimer

Figures

Figure 1
Lipid keratopathy secondary to corneal neovascularisation after penetrating keratoplasty.

Figure 2
(A) Two weeks after photodynamic therapy (PDT). (B) Significant regression of neovascularisation and lipid deposits 6 weeks after PDT. Visual acuity improved to 20/30.

See this image and copyright information in PMC

Similar articles

Topographical alteration in the cornea after photodynamic therapy for neovascularization in lipid keratopathy.
Igarashi T, Yaguchi C, Inage M, Suzuki H, Takahashi H. Igarashi T, et al. Jpn J Ophthalmol. 2009 Nov;53(6):655-657. doi: 10.1007/s10384-009-0739-7. Epub 2009 Dec 18. Jpn J Ophthalmol. 2009. PMID: 20020250 No abstract available.
Photodynamic therapy of corneal neovascularization with verteporfin.
Fossarello M, Peiretti E, Zucca I, Serra A. Fossarello M, et al. Cornea. 2003 Jul;22(5):485-8. doi: 10.1097/00003226-200307000-00018. Cornea. 2003. PMID: 12827058
Treatment of herpes zoster related corneal neovascularisation and lipid keratopathy by photodynamic therapy.
Goh YW, McGhee CNj, Patel DV, Barnes R, Misra S. Goh YW, et al. Clin Exp Optom. 2014 May;97(3):274-7. doi: 10.1111/cxo.12110. Epub 2013 Sep 22. Clin Exp Optom. 2014. PMID: 24112362
Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
Soubrane G, Bressler NM. Soubrane G, et al. Br J Ophthalmol. 2001 Apr;85(4):483-95. doi: 10.1136/bjo.85.4.483. Br J Ophthalmol. 2001. PMID: 11264143 Free PMC article. Review. No abstract available.
[Research status of photodynamic therapy for corneal neovascularization].
Wang HY, Wei RH, Zhao SZ. Wang HY, et al. Zhonghua Yan Ke Za Zhi. 2012 Jul;48(7):662-5. Zhonghua Yan Ke Za Zhi. 2012. PMID: 22943874 Review. Chinese.

See all similar articles

Cited by

Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).
Stevenson W, Cheng SF, Dastjerdi MH, Ferrari G, Dana R. Stevenson W, et al. Ocul Surf. 2012 Apr;10(2):67-83. doi: 10.1016/j.jtos.2012.01.005. Epub 2012 Jan 25. Ocul Surf. 2012. PMID: 22482468 Free PMC article. Review.
Available Therapeutic Options for Corneal Neovascularization: A Review.
Drzyzga Ł, Śpiewak D, Dorecka M, Wyględowska-Promieńska D. Drzyzga Ł, et al. Int J Mol Sci. 2024 May 17;25(10):5479. doi: 10.3390/ijms25105479. Int J Mol Sci. 2024. PMID: 38791518 Free PMC article. Review.
Corneal Cross-Linking With Verteporfin and Nonthermal Laser Therapy.
Alageel SA, Arafat SN, Salvador-Culla B, Kolovou PE, Jahanseir K, Kozak A, Braithwaite GJC, Ciolino JB. Alageel SA, et al. Cornea. 2018 Mar;37(3):362-368. doi: 10.1097/ICO.0000000000001473. Cornea. 2018. PMID: 29176450 Free PMC article.
Bilateral severe progressive idiopathic lipid keratopathy.
Levy J, Benharroch D, Lifshitz T. Levy J, et al. Int Ophthalmol. 2005 Aug-Oct;26(4-5):181-4. doi: 10.1007/s10792-007-9032-2. Epub 2007 Feb 17. Int Ophthalmol. 2005. PMID: 17308885
A CARE-compliant article: ipsilateral progressive idiopathic lipid keratopathy: A case report.
Pang Y, Zhang Q, Bao Y. Pang Y, et al. Medicine (Baltimore). 2019 Aug;98(35):e16589. doi: 10.1097/MD.0000000000016589. Medicine (Baltimore). 2019. PMID: 31464893 Free PMC article.

See all "Cited by" articles

References

1. Gohto Y, Obana A, Masakazu K, et al. Photodynamic therapy for corneal neovascularization using topically administered ATX-S10(Na). Ophthalmic Surg Lasers 2000;31:55–60. - PubMed
1. Gohto Y, Obana A, Masakazu K, et al. Treatment parameters for selective occlusion of experimental corneal neovascularization by photodynamic therapy using a water soluble photosensitizer, ATX-S10(Na). Exp Eye Res 2001;72:13–22. - PubMed
1. Fossarello M, Peiretti E, Zucca I, et al. Photodynamic therapy of corneal neovascularization with verteporfin. Cornea 2003;22:485–8. - PubMed
1. Primbs GB, Casey R, Wamser K, et al. Photodynamic therapy for corneal neovascularization. Ophthalmic Surg Lasers 1998;29:832–8. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database